1 / 14

PERICARDIAL EFFUSION

PERICARDIAL EFFUSION. INTRODUCTION. Presence of abnormal amount and/or character of fluid in the pericardial space Can be caused by LOCAL/SYSTEMIC/IDIOPATHIC causes Can be ACUTE or CHRONIC (symptoms)

candid
Télécharger la présentation

PERICARDIAL EFFUSION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PERICARDIAL EFFUSION

  2. INTRODUCTION • Presence of abnormal amount and/or character of fluid in the pericardial space • Can be caused by LOCAL/SYSTEMIC/IDIOPATHIC causes • Can be ACUTE or CHRONIC (symptoms) • Important implications for prognosis (intrathoracic neoplasm), diagnosis (myopercarditis) or both (dissecting of ascentding aorta) • Treatment directed at removal of pericardial fluid and alleviation of the underlying cause

  3. PHYSIOLOGY • Volume of fluid: 15-50 ml. • Essentially and ultrafiltrate of plasma • Total protein generally low. Albumin conc. HIGH. • Contribution of pericardial fluid: end-diastolic pressure (mostly RA,RV)ensure uniform contraction of the myocardium • Acute (80ml) vs. Chronic (up to 2lt).

  4. ETIOLOGY • As a component of any pericardial disorder or 2ry to a systemic disorder: • Acute idiopathic or viral pericaditis • Infectious: Viral, Purulent pericarditis, Tuberculous, HIV • Post MI/post cardiac surgery • Malignancy (lung, breast, hodgkin’s, mesothelioma) • Mediastinal radiation • Autoimmune disease • Dialysis, Ch. Renal failure • Hypothyroidism (myxedema), ovarian hyperstimulation synd. • Drugs: procainamide, isoniazid, hydralazine, anticoagulants.

  5. ETIOLOGY • HEMORRHAGIC PERICARDIAL EFFUSION: • Malignancy (26%) • Trans-catheter interventions and/or pacemaker insertion (18%) • Post-pericardiotomy syndrome (13%) • Complication of MI (free wall rupture, thrombolysis) (11%) • Idiopathic (10%) • Uremic (7%) • Aortic dissection (4%) • Trauma (3%) • Other (8%)

  6. CLINICAL- SYMPTOMS • CVS: chest pain, pericardial pain (relieved by sitting), light headedness, syncope, palpitations • RESP: cough, dyspnea, hoarsness • GI: hiccoughs • NEUR: anxiety, confusion

  7. CLINICAL- SIGNS • CVS:BECK’s triad of tamponade (hypotension, muffled heart sounds, jugular venous distension), pulsus paradoxus, pericardial friction rub, tachycardia, hepatojugular reflux. • RESP: tachypnea, decreased breath sounds, Ewart sign • GI: hepato-splenomegaly • EXTREMITIES: weakened peripheral pulses, edema, cyanosis.

  8. DIAGNOSIS • Suspect when: • All cases of acute pericarditis • Unexplained persistent fever +\- source. Purulent per. • New radiographic cardiomegaly without pul. Congestion. • Isolated left pleural effusion • Hemodynamic deterioration after MI, cardiac surgery, invasive cardiac procedures.

  9. APPRAOCH • Clinically, ECG, X-RAY. • Once pericardial effusion is suspected: • Establish the presence of effusion : clinically ECG, ECHO (sensitive, specific, hemodynamic significance • Assess the hemodynamic impact • Establish the cause

  10. Establish the presence of effusion • According to ACC/AHA/ASE 2003 • Clinically – insensitive and nonspecific. • ECG- low voltage QRS complexes <5mm in all limb leads, <10mm in V1-V6. (tamponade and inflammation); alternans in P and QRS complexes- pathognomonic. • ECHO: sensitive, specific, hemodynamic significance • CT, MRI

  11. Assess hemodynamic impact • Ranges from no significance mild compromisecardiactamponade • Factors determining the degree of hemodynamic compromise: • Volume • Rate of accumulation (acute vs. subacute) • Pericardium is scarred or adherent

  12. Establish the cause of effusion • Often recognized by the clinical setting in which it occurs (cancer, MI, hypothyroidism, renal failure) • Chance of diagnosis rises as the effusion is larger. (15/20% vs. 90%; why? Diag., aggressive approach) • Clinical assess.: size; +/- tamponade; inflammatory signs (chest pain, pericardial friction rub, fever diffused ST elev.) • Lab. Tests: CBC, chemistry+renal function, thyroid, anti dsDNA,complement, chst CT • Pericardiocentesis & biopsy : culture, cytology, PCR.protein,LDH,Glucose,RBC,WBC: do not distinguish exudate from transudate

  13. TREATMENT • CONSIDER: underlying disease, hemodynamic significance, presence of tamponade. • Underlying disease: infectious, malignant, uremic peric. MI, collagen vascular disease. • Cardiac tamponade: volume resuscitation (RA pressure 10-12mmHg). • Pericardial fluid drainage: percutaneous/ pericadiectomy.

  14. Summery • Abnormal amount/character of pericardial fluid • LOCAL/SYSTEMIC/IDIOPATHIC causes • ACUTE vs. CHRONIC • Clinical – not specific. Tamponade. • APPROACH: Clinically, ECG, X-RAY; Establish the presence of effusion ; Assess the hemodynamic impact Establish the cause • TREATMENT: underlying disease, hemodynamic significance, presence of tamponade.

More Related